Sinil Pharmaceutical Co. Ltd (KQ:012790) — Market Cap & Net Worth

$47.47 Million USD · ₩70.05 Billion KRW · Rank #22181

Market Cap & Net Worth: Sinil Pharmaceutical Co. Ltd (012790)

Sinil Pharmaceutical Co. Ltd (KQ:012790) has a market capitalization of $47.47 Million (₩70.05 Billion) as of September 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22181 globally and #1383 in its home market, demonstrating a 0.17% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sinil Pharmaceutical Co. Ltd's stock price ₩6060.00 by its total outstanding shares 11559561 (11.56 Million). Also see Sinil Pharmaceutical Co. Ltd asset portfolio for a full breakdown of the balance sheet.

Sinil Pharmaceutical Co. Ltd Market Cap History: 2015 to 2026

Sinil Pharmaceutical Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $66.83 Million to $47.47 Million (-4.09% CAGR). Also see Sinil Pharmaceutical Co. Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.

Index Memberships

Sinil Pharmaceutical Co. Ltd is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$234.31 Billion	0.02%	#662 of 1384
Kosdaq Composite Index KQ11	$234.31 Billion	0.02%	#662 of 1384

Weight: Sinil Pharmaceutical Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Sinil Pharmaceutical Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Sinil Pharmaceutical Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Sinil Pharmaceutical Co. Ltd stock price today for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.00x

Sinil Pharmaceutical Co. Ltd's market cap is 0.00 times its annual revenue

Industry average: 0.57x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.00x

Sinil Pharmaceutical Co. Ltd's market cap is 0.00 times its annual earnings

Industry average: 2.02x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2015	$66.83 Million	$44.70 Billion	$8.76 Billion	0.00x	0.01x
2016	$63.56 Million	$50.21 Billion	$10.04 Billion	0.00x	0.01x
2017	$57.49 Million	$50.94 Billion	$8.20 Billion	0.00x	0.01x
2018	$46.34 Million	$53.28 Billion	$5.71 Billion	0.00x	0.01x
2019	$48.89 Million	$60.65 Billion	$7.26 Billion	0.00x	0.01x
2020	$164.17 Million	$61.44 Billion	$7.54 Billion	0.00x	0.02x
2021	$86.01 Million	$61.75 Billion	$6.68 Billion	0.00x	0.01x
2022	$65.74 Million	$80.01 Billion	$12.16 Billion	0.00x	0.01x
2023	$60.40 Million	$89.14 Billion	$13.64 Billion	0.00x	0.00x
2024	$50.37 Million	$89.44 Billion	$14.30 Billion	0.00x	0.00x

Competitor Companies of 012790 by Market Capitalization

Companies near Sinil Pharmaceutical Co. Ltd in the global market cap rankings as of September 18, 2026. Review tangible net worth ratio of Sinil Pharmaceutical Co. Ltd to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Sinil Pharmaceutical Co. Ltd by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #520 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #619 globally with a market cap of $44.48 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #637 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Haleon plc (NYSE:HLN): Ranked #665 globally with a market cap of $41.22 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#520	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#619	GALDERMA GROUP AG	NYSE:GALDY	$44.48 Billion	$38.15
#637	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.10
#665	Haleon plc	NYSE:HLN	$41.22 Billion	$9.36

Sinil Pharmaceutical Co. Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Sinil Pharmaceutical Co. Ltd's market cap moved from $66.83 Million to $ 47.47 Million, with a yearly change of -4.09%.

Year	Market Cap	Change (%)
2026	₩47.47 Million	-0.16%
2025	₩47.55 Million	-5.60%
2024	₩50.37 Million	-16.60%
2023	₩60.40 Million	-8.13%
2022	₩65.74 Million	-23.56%
2021	₩86.01 Million	-47.61%
2020	₩164.17 Million	+235.77%
2019	₩48.89 Million	+5.51%
2018	₩46.34 Million	-19.39%
2017	₩57.49 Million	-9.56%
2016	₩63.56 Million	-4.89%
2015	₩66.83 Million	--

End of Day Market Cap According to Different Sources

On Sep 18th, 2026 the market cap of Sinil Pharmaceutical Co. Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$47.47 Million USD
MoneyControl	$47.47 Million USD
MarketWatch	$47.47 Million USD
marketcap.company	$47.47 Million USD
Reuters	$47.47 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Sinil Pharmaceutical Co. Ltd

KQ:012790 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$47.47 Million

₩70.05 Billion KRW

Market Cap Rank

#22181 Global

#1383 in Korea

Share Price

₩6060.00

Change (1 day)

+1.00%

52-Week Range

₩4900.00 - ₩6480.00

All Time High

₩50717.45